2016 - 2019 Development of a sensitive localization method for protein phosphorylation sites based on MS/MS spectral simulation
2008 - 2010 A view of the phosphoproteome in survival and cell death - Mass spectrometric analysis and imaging of cellular decision machineries
Papers (40):
Alejandro J. Da Silva, Hendrik S. E. Hästbacka, Jens C. Luoto, Rosemarie E. Gough, Leila S. Coelho-Rato, Leena M. Laitala, Benjamin T. Goult, Susumu Y. Imanishi, Lea Sistonen, Eva Henriksson. Proteomic profiling identifies a direct interaction between heat shock transcription factor 2 and the focal adhesion adapter talin-1. The FEBS Journal. 2024. 291. 21. 4830-4848
Susumu Y. Imanishi. Cyanobacterial classification and identification by MALDI-TOF MS. JSBMS Letters. 2023. 48. 3. 39-45
Tachi, M., Kobayashi, S., Tomita, K., Tanahashi, T., Imanishi, S.Y. Hierarchical clustering of liquid chromatography-tandem mass spectrometry data for screening of phosphodiesterase type 5 inhibitors and their analogues in adulterated dietary supplements. Journal of Chromatography A. 2022. 1678
Hirohiko Asukabe, Satoko Akahori, Ema Ueno, Takuma Nakayama, Ryuji Yamashita, Suzue Arii, Ken-ichi Harada, Susumu Y. Imanishi. Cyanobacterial Classification with the Toxicity Using MALDI Biotyper. Journal of the American Society for Mass Spectrometry. 2020. 31. 7. 1572-1578
Otto Kauko, Susumu Y. Imanishi, Evgeny Kulesskiy, Laxman Yetukuri, Teemu Daniel Laajala, Mukund Sharma, Karolina Pavic, Anna Aakula, Christian Rupp, Mikael Jumppanen, et al. Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1. Journal of Biological Chemistry. 2020. 295. 13. 4194-4211
Optimization of nanoLC-MS/MS measurement using TripleTOF 6600 : Analysis of α-casein digests. 2017. 22. 11-18
Investigation of proteome analysis for thrombosis research. 2017. 22. 273-276
Otto Kauko, Susumu Imanishi, Amanpreet Kaur, Daniel Laajala, Evgeny Kulesskiy, Mikael Jumppanen, Garry Corthals, Tero Aittokallio, Krister Wennerberg, Jukka Westermarck. Protein phosphatase 2A activity is a major determinant of therapy response in cancer cells. CANCER RESEARCH. 2015. 75
Lectures and oral presentations (10):
Confident and sensitive site localization using simulated phosphopeptide spectral library (Oral presentation)
(136th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama, Japan) 2016)
Academic life in the graduate school and Finland (Lecture)
(Autumn core program, Graduate School of Environmental and Human Sciences, Meijo University (Nagoya, Japan) 2015)